Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 200 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| SLC25A34 | ENSG00000162461 | 0.00 | 0 |
| NBL1 | ENSG00000158747 | 0.00 | 0 |
| PLA2G2E | ENSG00000188784 | 0.00 | 0 |
| CYP2J2 | ENSG00000134716 | 0.00 | 0 |
| SLC25A44 | ENSG00000160785 | 0.00 | 0 |
| APOA2 | ENSG00000158874 | 0.00 | 0 |
| FMO1 | ENSG00000010932 | 0.00 | 0 |
| CYP26A1 | ENSG00000095596 | 0.00 | 0 |
| CYP2E1 | ENSG00000130649 | 0.00 | 0 |
| IGF2 | ENSG00000167244 | 0.00 | 0 |
| CYP2R1 | ENSG00000186104 | 0.00 | 0 |
| SLC25A45 | ENSG00000162241 | 0.00 | 0 |
| RNASE10 | ENSG00000182545 | 0.00 | 0 |
| TXNDC16 | ENSG00000087301 | 0.00 | 0 |
| VRK1 | ENSG00000100749 | 0.00 | 0 |
| CYP1A1 | ENSG00000140465 | 0.00 | 0 |
| HSD11B2 | ENSG00000176387 | 0.00 | 0 |
| DPEP3 | ENSG00000141096 | 0.00 | 0 |
| CTRB2 | ENSG00000168928 | 0.00 | 0 |
| CCL5 | ENSG00000271503 | 0.00 | 0 |
|
Showing page 200 |
first page | previous page | next page | last page |